---
schema_version: "secwatch.filing_event.v1"
accession: "0000200406-26-000167"
form_type: "8-K"
ticker: "JNJ"
cik: "0000200406"
company_name: "JOHNSON & JOHNSON"
filed_at: "2026-08-04T12:48:52+00:00"
generated_at: "2026-08-04T12:50:07.780131+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jennifer Taubert, EVP and Worldwide Chairman of Innovative Medicine, to retire Sept 1, 2026

## Summary
- Jennifer Taubert retiring as EVP, Worldwide Chairman of Innovative Medicine and member of Executive Committee.
- Retirement effective September 1, 2026.
- No successor has been named at this time.
- Announcement made on August 4, 2026.

## SEC filing metadata
- accession: 0000200406-26-000167
- form_type: 8-K
- ticker: JNJ
- cik: 0000200406
- company_name: JOHNSON & JOHNSON
- filed_at: 2026-08-04T12:48:52+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/0000200406-26-000167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/jnj-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000200406-26-000167
- JSON: https://secwatch.observer/filing/0000200406-26-000167.json
- Plain text: https://secwatch.observer/filing/0000200406-26-000167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.